🔍 Search
Clinical tool Free

2-week-wait referral checker

Decision support for NICE NG12 suspected skin cancer referral.

Tool safetyDecision support, not a decision
  • Based on NICE NG12 suspected cancer referral guidance for the population in scope.
  • Not a substitute for local pathway rules; individual Cancer Alliance / trust 2WW criteria may differ.
  • Safety-netting is required for any patient not referred — document explicit return advice and worsening criteria.
  • Referral thresholds vary by Cancer Alliance and trust — check the local pathway.
  • Urgent clinical concern overrides tool output. If a lesion worries you, refer.
Lesion type
Major features (2 points each)
Minor features (1 point each)
Decision
2-week-wait referral 0 points

NICE NG12: refer on a suspected cancer pathway if the weighted 7-point checklist score is 3 or more.

NICE NG12 (2021) — suspected cancer: recognition and referral.
Important. Clinical judgement overrides the output. When in doubt, refer.

Source basis

  1. This page was launch-reviewed on 19 May 2026. See the source-control register for the NICE, NHS England, BAD, RCPath, WHO, AJCC / TNM and pivotal-trial sources used across the site; check live guidance and local MDT policy before applying recommendations.

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.